Ann and Robert H Lurie Childs Hosp

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Aplastic anaemia1 trial
• Childhood cancers1 trial
• Chronic myeloid leukaemia1 trial
• Lupus (SLE)1 trial
• Psoriatic arthritis1 trial

Phase

• Phase 23 trials
• Phase 11 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Novartis Pharmaceuticals4 trials

Running trials

• Recruiting

  Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

  NCT07354074· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Laura Arthur

• Recruiting

  Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

  NCT06751238· Phase 1· Novartis Pharmaceuticals· Source

  Contact: Tyler Sorensen

• Active, not recruiting

  A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

  NCT06581198· Phase 2· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Psoriatic arthritis1 recruiting

Closed trials

• Completed

  A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

  NCT03025698· Phase 2· Novartis Pharmaceuticals· Source